Sergey V. Orlov
Sochi, KDA 354376, Russian Federation
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 76 publications
Abstracts of the 36th World Congress on Ultrasound in Obstetrics and Gynecology, 4-7 September 2026, London, UK.
Journal: Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology
Published: July 06, 2026
Abstracts of the 36th World Congress on Ultrasound in Obstetrics and Gynecology, 4-7 September 2026, London, UK.
Journal: Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology
Published: July 06, 2026
Lorlatinib in advanced ALK-positive NSCLC after prior progression on ALK inhibitors: real-world experience in Russia.
Journal: Exploration of targeted anti-tumor therapy
Published: December 16, 2025
Molecularly guided precision therapy in metastatic adamantinoma: a case report.
Journal: Personalized medicine
Published: December 10, 2025
ENTRÉE Lung Platform Trial Sub-study 1: Phase II Randomized Efficacy and Safety Analysis of Feladilimab Plus Docetaxel Versus Docetaxel Monotherapy in Advanced/Recurrent NSCLC.
Journal: Clinical lung cancer
Published: October 30, 2025
Modulation of NK Cell Properties by ESKAPE Group Bacteria.
Journal: International journal of molecular sciences
Published: August 05, 2025
Central Nervous System Outcomes of Lazertinib Treatment in EGFR-Mutated Advanced NSCLC: Pooled Analysis From LASER201 and LASER301.
Journal: Clinical lung cancer
Published: May 30, 2025
Efficacy of immune checkpoint inhibitors rechallenge and metronomic cyclophosphamide with or without bevacizumab in metastatic nonsmall cell lung cancer.
Journal: Anti-cancer drugs
Published: May 01, 2025
Osimertinib long-term tolerability in patients with EGFRm NSCLC enrolled in the AURA program or FLAURA study.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: August 21, 2024
Predictive markers of response to immune checkpoint inhibitor rechallenge in metastatic non-small cell lung cancer.
Journal: Exploration of targeted anti-tumor therapy
Published: July 18, 2024
Capmatinib in MET exon 14-mutated non-small-cell lung cancer: final results from the open-label, phase 2 GEOMETRY mono-1 trial.
Journal: The Lancet. Oncology
Published: May 08, 2024
Response to trametinib, hydroxychloroquine, and bevacizumab in a young woman with NRAS-mutated metastatic intrahepatic cholangiocarcinoma: a case report.
Journal: Exploration of targeted anti-tumor therapy
Published: February 24, 2024
Last Updated: 09/26/2026